Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29

Mar 22, 2021 ‐ Mar 24, 2021



Sessions

Short Talk: Identifying Effective Subtype-Specific Treatment Responses in Hepatocellular Carcinoma in Genetically Engineered Mouse Models

Mar 24, 2021 11:40am ‐ Mar 24, 2021 11:55am

Speaker(s):

Short Talk: A Cytosolic Complex Between the Nuclear Export Protein XPO7 and Sterile 20-like Kinase (SLK) Drives Cholangiocarcinoma, and Reveals a Translatable Therapeutic Target

Mar 24, 2021 11:55am ‐ Mar 24, 2021 12:10pm

Speaker(s):

Short Talk: Inhibition of YAP Activation Induces Cell Senescence and Autophagy while Blocking Cell Proliferation in Cholangiocarcinoma (CCA)

Mar 24, 2021 12:10pm ‐ Mar 24, 2021 12:25pm

Speaker(s):

Short Talk: Tumor Methionine Metabolism Drives T-Cell Exhaustion in Hepatocellular Carcinoma

Mar 24, 2021 12:25pm ‐ Mar 24, 2021 12:40pm

Speaker(s):

Short Talk: Overcoming HCC Drug Resistance byTargeting Metabolic Flexibility Conferred by p53

Mar 24, 2021 12:40pm ‐ Mar 24, 2021 12:55pm

Speaker(s):

Closing Remarks (Organizers) iconClosing Remarks (Organizers)

Preview Available

Closing Remarks (Organizers)

Mar 24, 2021 12:55pm ‐ Mar 24, 2021 1:05pm


Hepatobiliary Cancers: Pathobiology and Translational Advances | EK29

Mar 24, 2021 2:00pm ‐ Mar 24, 2021 2:05pm